chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PREVNAR given 5/13/2015. On 5/15/15 she c/o redness at injection site (R) Deltoid). On 5/19/15 she returned to office with c/o (R) upper arm redness, warmth and tenderness.
MEDIUM/LARGE, SPREAD OUT, RED LUMP RASH, VERY ITCHY, WARM TO THE TOUCH, LOOKS LIKE LARGE IN-GROWNS. ON OPPOSITE SIDE OF INJECTION SITE (LEFT DELTOID), THEY ARE ON MY RIGHT SHOULDER BLADE.
Initial report received from a healthcare professional on 07 March 2013. A 60-year-old male patient, had received first intradermal dose of FLUZONE ID (Lot number: UT4466BA, expiry date: 04/02/2013) on the right deltoid on 11 January 2013. The patient had no known allergies, previous medications or pre-medical history (PMH). The patient denied any illness at the time of vaccination and concomitant medications were not reported. On 12 January 2013, the patient had initially experienced swelling and bruising at the site however a hard pink nodule persisted at the injection site. Corrective treatments and relevant laboratory data were not reported. At the time of this report, the outcome of the events was unknown. Documents held by sender: none.
This case was reported by a physician via an injectables and vaccines distributor and described the occurrence of convulsion in a male subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline).  On 21 October 2008 the subject received a dose of FLULAVAL (unknown).  At an unspecified time after vaccination with FLULAVAL, the subject experienced convulsion.  It was suggested that the subject was seen in the emergency room.  Limited information was available.  This case was assessed as medically serious by GSK.  At the time of reporting the outcome of the event was unspecified.  The person reporting this event was a distributor who sold the product to another distributor who then sold it to a medical doctor's office.  The medical doctor's office contacted the second distributor with the limited information.  It was reported that three subjects experienced convulsions and a female subject experienced a drop in her blood sugar and weakness and was taken to the emergency room.  Linked case numbers include A0754338A and A0754339A.
3 er visits, sent home told to keep her feet raised. Wouldn't allow anyone in with her.  Died 5/28/22
8 days later left shoulder is red, noticeable swollen, hot and  itchy.
dizziness; perspiration while sleeping; warmness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HYPERHIDROSIS (perspiration while sleeping), FEELING HOT (warmness) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DIZZINESS (dizziness), HYPERHIDROSIS (perspiration while sleeping), FEELING HOT (warmness) and HEADACHE (Headache). At the time of the report, DIZZINESS (dizziness), HYPERHIDROSIS (perspiration while sleeping), FEELING HOT (warmness) and HEADACHE (Headache) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant medications were provided.  No treatment information provided
Severe Headache  Severe Body Aches Severe Skin Hypersensitivity  Tinnitus  Nausea  Vaccination Completed 12/27- Time Course 72 Hours
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Dec2020 at 11:00 as dose 1, single (Lot number: EIH9099), in left arm, on 06Jan2021 at 09:00 as dose 2, single (Lot number: el0142), in left arm, on 06Oct2021 at 16:00 as dose 3 (booster), single (Lot number: ff2587), in left arm and on 26Apr2022 at 13:00 as dose 4 (booster), single (Lot number: fk4989) at the age of 70 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 29Jun2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: indication: Treatment of COVID-19; (29Jun2022) positive, notes: Day 8 still positive for COVID. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical Course: Antiviral details, Paxlovid (Lot number: GC2897) for COVID 19 Treatment, from 22Jun2022 to 26Jun2022. When taking the 5days course started to feel better. Day 8 still positive for COVID. About day 10 or 11 symptoms increased with congestion, fever and body aches. Now on Day 14 and continue with congestion cough and fatigue. I believe this situation may represent a rebound effect.
Fever to 101 degrees F and rash - scattered erythematous popular rash, some with vesicular, arms/legs/
A legal complaint was received from an attorney concerning a male child who reportedly received Hib-Titer, Tri-Immunol, Engerix B, Recombivax-HB, and DPT vaccines during the period from approximately 1997 to 1999. The legal complaint states that the child subsequently developed toxic neurological effects of mercury poisoning (namely autism) as a result of receiving vaccinations containing thimerosal. Mercury poisoning and autism were considered medically important (OMIC).
I received the vaccine in my left arm on a Friday and woke up on Sunday (two days later) with swelling under my left eyelid with itching. In the late afternoon, my right upper eyelid began itching a little. The following day both upper, lower and sides of my eyelids were itching. I placed ice packs on my eyes and the swelling went down the following day. But, the itching remained and traveled to my eyebrows. My eyelids and eyebrows itched off and on for 11 days. I had a slight rash from scratching my eyelids. The only other effects I felt were being slightly tired with a slight headache off and on. I took Benadryl for a few days, but I couldn't tell if it helped much. I drank a lot of water on day 10 and on day 11 my symptoms were gone. I have never had any facial fillers or botox.
- Chest pain and enlarged left ventricle/ - Allergic reaction resulting in swelling of the throat and airways, subsided after 24 hours - Lymphadenopathy and sharp pain in many lymph nodes - Tingling in the legs, spread from one to both legs and now arms - Extreme pain and shortness of breath when walking - On and off oscillating medium and low grade fever (103F to 100F)
Rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Rash on her arm). At the time of the report, RASH (Rash on her arm) had not resolved.            No concomitant medication was reported. The treatment information was unknown. On Sunday 04Apr21 at night time the rash came  back and is still there. Action taken with mRNA-1273 in response to the event was not applicable.
Itching, redness around injection site approximately 5x7cm. Rash  to upper part of upper arm,  as of this report 5 hives to upper arm,  itching to left side of face and neck.    All these I have experienced with previous vaccines that are not latex free.....especially if if syringes are loaded via drawing fluid from a vial.  As of this writing symptoms are not worsening but not totally resolved.
Tinnitus; buzzing sound in ears; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A 62 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Jun2021 (Lot number: AW0181) at the age of 62 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE-1, Lot Number: AW0186.), administration date: 27May2021, when the patient was 62 years old, for COVID-19 immunization. The following information was reported: TINNITUS (non-serious) with onset 22Jun2021, outcome "not recovered", described as "Tinnitus; buzzing sound in ears".  Additional information: The patient denied any medications, medical conditions, labs, testing, or treatments relevant to these events. No emergency room and no physician office. Prior vaccinations (within 4 weeks) and other vaccinations within four weeks prior to the first administration date of the suspect vaccines were none. Patients medical history (including any illness at time of vaccination), family medical history relevant to AE(s) and relevant tests were none.  No follow-up attempts are possible. No further information is expected.  Follow-Up (22Jul2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021783671 Same reporter/product/event, different patient
Patient stated a history of Syncope only, measures taken to decrease response such as patient lying down during Tdap administration. Within 2 minutes noted diaphoresis, pale skin, patient fainted no injury sustained, eyes rolled back and body became rigid. Event lasted less than 5 minutes, vitals stable and patient fully reponsive within 5 minutes.
Sore throat, runny nose 6/15; syncope 6/15/06.
Patient was fine immediately following vaccination.  Was waiting in the wellness room until his 15 minutes passed to leave.  He walked out of the room to the front of the store a few minutes later (he later stated this was because he had started to feel nauseous).  Patient passed out and fell into a couple of folding chairs.  Initially unable to be woken up but came to with smelling salts.  Appeared to have a seizure for several seconds after waking back up.  At that time a tech called 911.  We monitored blood pressure and pulse until EMTs arrived.  No meds administered except for the smelling salts.
He developed a fever around 9:30 am and was very cranky and irritable, which is VERY out of character.  By 10:00 his temperature was around 101 and he had a two hour screaming/crying/uncontrollable melt down.  I've never seen him do anything like this prior or since.  He quieted down around noon or a little after and was whiny and sleepy/cranky the rest of the day.
This spontaneous report has been received from a medical assistant and refers to an unspecified number of patients of unknown ages and genders. The patients' medical histories, concurrent conditions, drug allergies/reactions, and concomitant therapies were not reported. The medical assistant reported that on unspecified dates, an unspecified number of patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # M034780, expiration date 15-APR-2019; doses, routes of administration, and frequencies were not reported) for prophylaxis. The vaccine data logger measured a temperature range from 0°C to 1°C for a total time frame of 22 minutes. Previous temperature excursions temperature ranges from 0°C to 1°C and 9°C to 25°C for a total time frame of 1 hour 30 minutes. No adverse effects were reported, and no product quality complaint (PQC) was involved. This is one of two reports from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1704USA001657:
Unconsolable crying upon waking at midnight following vaccinations lasting about 6 hours.  Child cried during periods of sleep. Fever 103 degrees Fahrenheit and loss of appetite.  10/07/04: Slept most of the day.  10/07/04: evening and crying/screaming unconsolably for 5 hours.  10/08/04: slept most of the day. Fever decreased, appetite improved. Child given infant Advil.  10/08/04: afternoon-continues periods of unconsolable crying.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient reported tingling sensation in hand after administration of vaccine, she has some pre-existing nerve issues relating to carpal tunnel syndrome on both sides, followed-up with patient later in the evening (~7pm), and she stated she felt a little dizzy when doing some computer work and stopped, but that her tingling sensation was subsiding. She was previously instructed to contact her primary care doctor, which she did, and she plans to follow up with the office the morning.
Site soreness. 24 hours had sharp pain in left chest muscle.lastef over an hour. Hurt to take deep breaths. Them couldn't get warm. Shivering. Felt fevered but no elevated temp registered. Lasted about another hour. Tired/weak after. Noal next day.
SEVERE ITCHING STARTED TO OCCUR ON THE UPPER BODY ABOUT 52 HOURS AFTER VACCINE ADMINISTRATION. SLIGHT RASH COULD HAVE ALSO OCCURED, BUT UNSURE IF ITCHING AREA CAUSED THE REDNESS.
I will need surgery to correct the swelled varicose veins in my testicles.  Symptoms include pain and swelling in testicles.
sore throat; difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and DYSPHAGIA (difficulty swallowing) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No medical history provided. No concomitant medication details provided.     On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and DYSPHAGIA (difficulty swallowing). At the time of the report, OROPHARYNGEAL PAIN (sore throat) and DYSPHAGIA (difficulty swallowing) had not resolved.            No treatment details provided.  Patient got the second dose of today Moderna Vaccine today 21May2021 around 1pm in the upper left arm (non-dominant) (Lot# 023C21A and expiration date is unknown)- started to experience sore throat and is having difficulty swallowing about 1.5 hours later after receiving Moderna vaccine but can still breath fine. Symptoms are still ongoing. Patient did not have any symptoms with the first Moderna vaccine that was giving in the upper left arm (got the 1st dose on 4/23/21, Lot # 044B21A and expiration date is unknown). Not completely sure if lot number is correct for the first Moderna vaccine due to trouble reading the hand writing. Had contacted vaccinating facility (Rite Aid) first but was directed to call Moderna. Consent to have safety team follow up via email. Consent to have Moderna contact health care provider and vaccinating facility with follow up questions.
Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back; Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back; Generalized body aches; Extremely sick; No energy; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Extremely sick), ASTHENIA (No energy), SKIN MASS (Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back), PRURITUS (Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back) and MYALGIA (Generalized body aches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ESCITALOPRAM and FAMOTIDINE for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced ILLNESS (Extremely sick), ASTHENIA (No energy) and MYALGIA (Generalized body aches). On 28-Feb-2021, the patient experienced SKIN MASS (Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back) and PRURITUS (Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back). On 14-Feb-2021, ILLNESS (Extremely sick), ASTHENIA (No energy) and MYALGIA (Generalized body aches) had resolved. At the time of the report, SKIN MASS (Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back) and PRURITUS (Itchy bumps on top of head/itchy bumps on cheeks/itchy bumps on  forehead/itchy bumps on her back) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes a Medrol dose pack and a steroid cream..
On 1/22/21 injection site swelled back up and was itchy.  Subsided after a day. On 1/27/21, woke up and arm was itchy, swollen and had a large red circle around the injection site.  The injection site itself was red and then circled by the red ring.
Information has been received from a physician concerning a female patient who on 17-APR-2007 was vaccinated with a dose of ProQuad (Lot# 656312/0297U). It was reported that the patient developed redness. Swelling, tenderness and induration at injection site on an unspecified date after vaccination, approximately April 2007. Additional information has been requested. This is one of several reports received from the same source.
Left lower limb swelling; left leg pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of OEDEMA PERIPHERAL (Left lower limb swelling), PAIN IN EXTREMITY (left leg pain) and ARTHRALGIA (Joint pain) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Arthritis.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OEDEMA PERIPHERAL (Left lower limb swelling), PAIN IN EXTREMITY (left leg pain) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL at an unspecified dose and frequency and CODEINE at an unspecified dose and frequency. At the time of the report, OEDEMA PERIPHERAL (Left lower limb swelling), PAIN IN EXTREMITY (left leg pain) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: F/U received on 30-APR-2021,No New Information reported.
This spontaneous report was received from a 65 year old female health care professional reporting on herself. Concomitant medication: none. Drug reactions/allergies included: penicillin and unspecified sulfa drugs. In 2006 the patient was vaccinated with RECOMBIVAX HB (dosing regimen unspecified). Concomitant Medication: none. Patient reports that on an unspecified date "around 10 years ago" (approximately in 2006) she received an unspecified dose of RECOMBIVAX HB vaccine due to healthcare employment requirements. Patients reported that within "4 to 6 hours" after receiving the vaccine she experienced "a high fever of 103 degrees and for the next 3 days she felt like she had a bad flu. Lab diagnostics studies performed: none. Patient was seen by the physician. The manufacturer of the vaccine was unspecified therefore RECOMBIVAX HB could not be ruled out. No further information was provided. The outcome of the events was reported as resolved approximately in 2006. Causality assessment was not reported. Additional information has been requested.
The patient received the Pfizer covid vaccine for the first shot and was given the moderna covid shot for the 2nd dose
This spontaneous report was received from a pharmacist referring to a male patient of unknown age. The patient's pertinent medical history, current conditions and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23, 0.5 ml (strength, route of administration, lot # and expiration date were not reported). On an unknown date, the patient experienced a severe pain at the injection site that lasted much longer than usual. The outcome of injection site pain was not reported. The relationship between of injection site pain and the suspect therapy was unknown at the time of the report. No product quality complaint (PQC) was involved in the report. Additional information has been requested.
PATIENT HAD 2 IMMUNIZATION CARDS AND WAS PRESENTED THE SECOND CARD THAT DID NOT REFLECT THE ADDED DOSE THAT I ADMINISTERED ON THE ABOVE DATE